Skip to content

Laser Hair Removal for Treatment of Pilonidal Disease

Laser Hair Removal for Primary Treatment of Pilonidal Disease Requiring Surgical Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03949140
Enrollment
22
Registered
2019-05-14
Start date
2019-02-18
Completion date
2021-10-30
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Disease

Brief summary

This project is a pilot study to determine if symptomatic pilonidal disease can be primarily managed with laser hair removal vs surgery.

Detailed description

This project will consist of surgical evaluation in pediatric surgery or colorectal surgery clinics, referral to dermatology clinic for informed consent, and if enrolled, participation in up to 8 laser hair removal sessions with regular follow-up for a period of 2 years after completion of therapy.

Interventions

Those who consent to participate in the study will be treated with up to 8 sessions of laser hair removal utilizing a long-pulsed laser to the natal cleft at treatment intervals of 4-6 weeks.

Sponsors

Syneron Candela
CollaboratorINDUSTRY
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

Patients with symptomatic pilonidal disease, who meet criteria for surgical intervention: * Experience two or more episodes of infection or abscess in the past 12 months * Have pain or drainage for a total of more than 1 month in the past 12 months * Missed a total of more than 1 week of school or work in the past 12 months * English-speaking

Exclusion criteria

* Patients who have co-morbidities that prevent them from becoming a surgical candidate * Previous history of laser hair removal in the gluteal cleft (prior to initial enrollment) * Previous excision of pilonidal sinus (prior to initial enrollment) * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Incidence of disease-free remissionup to 2 yearsDisease free rate among those subjects who only required laser therapy. Disease-free remission will be assessed at 12 and 24 months.
Disease recurrence rate among subjects who subsequently require surgical intervention.up to 2 yearsRate of recurrence of pilonidal disease among subjects who participated in the study but also required surgical intervention.

Secondary

MeasureTime frameDescription
Assessment of Pain via Promis 3A Pain Short Formup to 18 monthsThis study will investigate qualitative outcomes including pain. Pain will be assessed via the Promis 3A Pain Short Form at 6, 9, and 18 months. This is a one question survey that has participants rate the intensity of their pain over the last 7 days, on average. The scale is from 0-10 where 0 is no pain and 10 is the worst pain imaginable.
Characterization of the degree of intervention required to obtain positive results.up to 2 yearsIncision and drainage vs. need for larger excision, requirement for oral antibiotics, and the number of emergency room visits, or hospital admissions related to pilonidal disease.
Cost-benefit analysis of laser hair-treated patients versus matched historical control.up to 2 yearsEvaluate total cost to the health care system relative to period of disease-free remission.
Number of Days Participants Experience Drainageup to 18 monthsThis study will investigate qualitative outcomes including assessment of drainage. This will be reported as the number of days participants experienced drainage since last follow up, assessed at 6, 9, and 18 month follow up.
Number of missed school or work daysUp to 18 monthsThis study will investigate qualitative outcomes including the number of missed school or work days at each follow up, 6, 9, and 18 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026